How common are approved EB-2 NIW petitions?

EB-2 NIW petition outcomes vary based on the strength of evidence, the specific criteria addressed, and the adjudicating officer. Each case is evaluated individually based on its own merits and documentation.

How does the Cancer System Biology industry affect EB-2 NIW petition outcomes?

The Cancer System Biology sector has unique considerations for EB-2 NIW petitions. USCIS evaluates whether the petitioner's qualifications and contributions align with the specific requirements of the visa category. Industry context matters for demonstrating the significance and impact of the petitioner's work.

approved EB-2 (NIW) RFE Issued

Postdoc Fellow

Cancer System Biology · China · 2025-11-22

Processing Time

516 days

Decision Date

2025-11-22

This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop mathematical and computational models to optimize cancer treatment strategies, aiming to extend patient survival time, improve treatment efficacy, and address challenges such as treatment resistance and variability in therapeutic response.

Framework Evaluation

3 of 3 criteria met

1 Substantial Merit and National Importance Met

The endeavor addresses the major health and economic burdens of cancer in the U.S. through models that improve patient quality of life and clinical planning.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 10 journal articles and 342 citations, along with support from the NCI, demonstrates significant progress and influence in the field.

3 Waiver Benefit Met

On balance, the petitioner's contributions to precision medicine and computational biology justify waiving the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on a strong scholarly record including 10 peer-reviewed journal articles, 4 conference papers, and a book chapter with 342 citations. The petitioner also demonstrated expertise through 30 peer reviews and received support from the National Cancer Institute (NCI).

Request for Evidence (RFE)

Successfully Addressed

USCIS issued an RFE on August 27, 2025. The petitioner responded with updated information regarding their research and record, which successfully addressed concerns regarding their positioning to advance the endeavor.

RFE Targets

Well-positioned to Advance the Endeavor

Evidence

Evidence Types

Peer Reviewed Publications

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-11-22.

Browse all cases

View Original

At a Glance

Outcome approved

Processing 516 days

RFE Issued

Criteria Met 3 / 3

Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813

Success Rate 53.7%

Sustained 2,046

Dismissed 1,671

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist